Global OTC Drug Market Insight and Forecast to 2026
The research team projects that the OTC Drug market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Bayer HealthCare
Bristol Myers Squibb
Pfizer
GlaxoSmithKline (GSK)
BioGaia
Johnson&Johnson
Chr. Hansen
AstraZeneca
Sanofi
Bukwang Pharmaceutica
DSM
Herbalife
Cipla
Eisai
Friggs
CoLucid
Euradite
Eli Lilly
Daiichi Sankyo
By Type
Class A
Class B
By Application
Hospital
Clinic
Household
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of OTC Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the OTC Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the OTC Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Bayer HealthCare
Bristol Myers Squibb
Pfizer
GlaxoSmithKline (GSK)
BioGaia
Johnson&Johnson
Chr. Hansen
AstraZeneca
Sanofi
Bukwang Pharmaceutica
DSM
Herbalife
Cipla
Eisai
Friggs
CoLucid
Euradite
Eli Lilly
Daiichi Sankyo
By Type
Class A
Class B
By Application
Hospital
Clinic
Household
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of OTC Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the OTC Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the OTC Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Drug Market Perspective (2021-2026)
2.2 OTC Drug Growth Trends by Regions
2.2.1 OTC Drug Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 OTC Drug Historic Market Size by Regions (2015-2020)
2.2.3 OTC Drug Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global OTC Drug Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global OTC Drug Revenue Market Share by Manufacturers (2015-2020)
3.3 Global OTC Drug Average Price by Manufacturers (2015-2020)
4 OTC DRUG PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America OTC Drug Market Size (2015-2026)
4.1.2 OTC Drug Key Players in North America (2015-2020)
4.1.3 North America OTC Drug Market Size by Type (2015-2020)
4.1.4 North America OTC Drug Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia OTC Drug Market Size (2015-2026)
4.2.2 OTC Drug Key Players in East Asia (2015-2020)
4.2.3 East Asia OTC Drug Market Size by Type (2015-2020)
4.2.4 East Asia OTC Drug Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe OTC Drug Market Size (2015-2026)
4.3.2 OTC Drug Key Players in Europe (2015-2020)
4.3.3 Europe OTC Drug Market Size by Type (2015-2020)
4.3.4 Europe OTC Drug Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia OTC Drug Market Size (2015-2026)
4.4.2 OTC Drug Key Players in South Asia (2015-2020)
4.4.3 South Asia OTC Drug Market Size by Type (2015-2020)
4.4.4 South Asia OTC Drug Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia OTC Drug Market Size (2015-2026)
4.5.2 OTC Drug Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia OTC Drug Market Size by Type (2015-2020)
4.5.4 Southeast Asia OTC Drug Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East OTC Drug Market Size (2015-2026)
4.6.2 OTC Drug Key Players in Middle East (2015-2020)
4.6.3 Middle East OTC Drug Market Size by Type (2015-2020)
4.6.4 Middle East OTC Drug Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa OTC Drug Market Size (2015-2026)
4.7.2 OTC Drug Key Players in Africa (2015-2020)
4.7.3 Africa OTC Drug Market Size by Type (2015-2020)
4.7.4 Africa OTC Drug Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania OTC Drug Market Size (2015-2026)
4.8.2 OTC Drug Key Players in Oceania (2015-2020)
4.8.3 Oceania OTC Drug Market Size by Type (2015-2020)
4.8.4 Oceania OTC Drug Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America OTC Drug Market Size (2015-2026)
4.9.2 OTC Drug Key Players in South America (2015-2020)
4.9.3 South America OTC Drug Market Size by Type (2015-2020)
4.9.4 South America OTC Drug Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World OTC Drug Market Size (2015-2026)
4.10.2 OTC Drug Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World OTC Drug Market Size by Type (2015-2020)
4.10.4 Rest of the World OTC Drug Market Size by Application (2015-2020)
5 OTC DRUG CONSUMPTION BY REGION
5.1 North America
5.1.1 North America OTC Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia OTC Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe OTC Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia OTC Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia OTC Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East OTC Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa OTC Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania OTC Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America OTC Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World OTC Drug Consumption by Countries
5.10.2 Kazakhstan
6 OTC DRUG SALES MARKET BY TYPE (2015-2026)
6.1 Global OTC Drug Historic Market Size by Type (2015-2020)
6.2 Global OTC Drug Forecasted Market Size by Type (2021-2026)
7 OTC DRUG CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global OTC Drug Historic Market Size by Application (2015-2020)
7.2 Global OTC Drug Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN OTC DRUG BUSINESS
8.1 Bayer HealthCare
8.1.1 Bayer HealthCare Company Profile
8.1.2 Bayer HealthCare OTC Drug Product Specification
8.1.3 Bayer HealthCare OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Bristol Myers Squibb
8.2.1 Bristol Myers Squibb Company Profile
8.2.2 Bristol Myers Squibb OTC Drug Product Specification
8.2.3 Bristol Myers Squibb OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Pfizer
8.3.1 Pfizer Company Profile
8.3.2 Pfizer OTC Drug Product Specification
8.3.3 Pfizer OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 GlaxoSmithKline (GSK)
8.4.1 GlaxoSmithKline (GSK) Company Profile
8.4.2 GlaxoSmithKline (GSK) OTC Drug Product Specification
8.4.3 GlaxoSmithKline (GSK) OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 BioGaia
8.5.1 BioGaia Company Profile
8.5.2 BioGaia OTC Drug Product Specification
8.5.3 BioGaia OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson&Johnson
8.6.1 Johnson&Johnson Company Profile
8.6.2 Johnson&Johnson OTC Drug Product Specification
8.6.3 Johnson&Johnson OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Chr. Hansen
8.7.1 Chr. Hansen Company Profile
8.7.2 Chr. Hansen OTC Drug Product Specification
8.7.3 Chr. Hansen OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 AstraZeneca
8.8.1 AstraZeneca Company Profile
8.8.2 AstraZeneca OTC Drug Product Specification
8.8.3 AstraZeneca OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Sanofi
8.9.1 Sanofi Company Profile
8.9.2 Sanofi OTC Drug Product Specification
8.9.3 Sanofi OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Bukwang Pharmaceutica
8.10.1 Bukwang Pharmaceutica Company Profile
8.10.2 Bukwang Pharmaceutica OTC Drug Product Specification
8.10.3 Bukwang Pharmaceutica OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 DSM
8.11.1 DSM Company Profile
8.11.2 DSM OTC Drug Product Specification
8.11.3 DSM OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Herbalife
8.12.1 Herbalife Company Profile
8.12.2 Herbalife OTC Drug Product Specification
8.12.3 Herbalife OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Cipla
8.13.1 Cipla Company Profile
8.13.2 Cipla OTC Drug Product Specification
8.13.3 Cipla OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Eisai
8.14.1 Eisai Company Profile
8.14.2 Eisai OTC Drug Product Specification
8.14.3 Eisai OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 Friggs
8.15.1 Friggs Company Profile
8.15.2 Friggs OTC Drug Product Specification
8.15.3 Friggs OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 CoLucid
8.16.1 CoLucid Company Profile
8.16.2 CoLucid OTC Drug Product Specification
8.16.3 CoLucid OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Euradite
8.17.1 Euradite Company Profile
8.17.2 Euradite OTC Drug Product Specification
8.17.3 Euradite OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Eli Lilly
8.18.1 Eli Lilly Company Profile
8.18.2 Eli Lilly OTC Drug Product Specification
8.18.3 Eli Lilly OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Daiichi Sankyo
8.19.1 Daiichi Sankyo Company Profile
8.19.2 Daiichi Sankyo OTC Drug Product Specification
8.19.3 Daiichi Sankyo OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of OTC Drug (2021-2026)
9.2 Global Forecasted Revenue of OTC Drug (2021-2026)
9.3 Global Forecasted Price of OTC Drug (2015-2026)
9.4 Global Forecasted Production of OTC Drug by Region (2021-2026)
9.4.1 North America OTC Drug Production, Revenue Forecast (2021-2026)
9.4.2 East Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.3 Europe OTC Drug Production, Revenue Forecast (2021-2026)
9.4.4 South Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.6 Middle East OTC Drug Production, Revenue Forecast (2021-2026)
9.4.7 Africa OTC Drug Production, Revenue Forecast (2021-2026)
9.4.8 Oceania OTC Drug Production, Revenue Forecast (2021-2026)
9.4.9 South America OTC Drug Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World OTC Drug Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of OTC Drug by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of OTC Drug by Country
10.2 East Asia Market Forecasted Consumption of OTC Drug by Country
10.3 Europe Market Forecasted Consumption of OTC Drug by Countriy
10.4 South Asia Forecasted Consumption of OTC Drug by Country
10.5 Southeast Asia Forecasted Consumption of OTC Drug by Country
10.6 Middle East Forecasted Consumption of OTC Drug by Country
10.7 Africa Forecasted Consumption of OTC Drug by Country
10.8 Oceania Forecasted Consumption of OTC Drug by Country
10.9 South America Forecasted Consumption of OTC Drug by Country
10.10 Rest of the world Forecasted Consumption of OTC Drug by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 OTC Drug Distributors List
11.3 OTC Drug Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 OTC Drug Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Drug Market Perspective (2021-2026)
2.2 OTC Drug Growth Trends by Regions
2.2.1 OTC Drug Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 OTC Drug Historic Market Size by Regions (2015-2020)
2.2.3 OTC Drug Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global OTC Drug Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global OTC Drug Revenue Market Share by Manufacturers (2015-2020)
3.3 Global OTC Drug Average Price by Manufacturers (2015-2020)
4 OTC DRUG PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America OTC Drug Market Size (2015-2026)
4.1.2 OTC Drug Key Players in North America (2015-2020)
4.1.3 North America OTC Drug Market Size by Type (2015-2020)
4.1.4 North America OTC Drug Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia OTC Drug Market Size (2015-2026)
4.2.2 OTC Drug Key Players in East Asia (2015-2020)
4.2.3 East Asia OTC Drug Market Size by Type (2015-2020)
4.2.4 East Asia OTC Drug Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe OTC Drug Market Size (2015-2026)
4.3.2 OTC Drug Key Players in Europe (2015-2020)
4.3.3 Europe OTC Drug Market Size by Type (2015-2020)
4.3.4 Europe OTC Drug Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia OTC Drug Market Size (2015-2026)
4.4.2 OTC Drug Key Players in South Asia (2015-2020)
4.4.3 South Asia OTC Drug Market Size by Type (2015-2020)
4.4.4 South Asia OTC Drug Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia OTC Drug Market Size (2015-2026)
4.5.2 OTC Drug Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia OTC Drug Market Size by Type (2015-2020)
4.5.4 Southeast Asia OTC Drug Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East OTC Drug Market Size (2015-2026)
4.6.2 OTC Drug Key Players in Middle East (2015-2020)
4.6.3 Middle East OTC Drug Market Size by Type (2015-2020)
4.6.4 Middle East OTC Drug Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa OTC Drug Market Size (2015-2026)
4.7.2 OTC Drug Key Players in Africa (2015-2020)
4.7.3 Africa OTC Drug Market Size by Type (2015-2020)
4.7.4 Africa OTC Drug Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania OTC Drug Market Size (2015-2026)
4.8.2 OTC Drug Key Players in Oceania (2015-2020)
4.8.3 Oceania OTC Drug Market Size by Type (2015-2020)
4.8.4 Oceania OTC Drug Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America OTC Drug Market Size (2015-2026)
4.9.2 OTC Drug Key Players in South America (2015-2020)
4.9.3 South America OTC Drug Market Size by Type (2015-2020)
4.9.4 South America OTC Drug Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World OTC Drug Market Size (2015-2026)
4.10.2 OTC Drug Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World OTC Drug Market Size by Type (2015-2020)
4.10.4 Rest of the World OTC Drug Market Size by Application (2015-2020)
5 OTC DRUG CONSUMPTION BY REGION
5.1 North America
5.1.1 North America OTC Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia OTC Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe OTC Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia OTC Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia OTC Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East OTC Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa OTC Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania OTC Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America OTC Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World OTC Drug Consumption by Countries
5.10.2 Kazakhstan
6 OTC DRUG SALES MARKET BY TYPE (2015-2026)
6.1 Global OTC Drug Historic Market Size by Type (2015-2020)
6.2 Global OTC Drug Forecasted Market Size by Type (2021-2026)
7 OTC DRUG CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global OTC Drug Historic Market Size by Application (2015-2020)
7.2 Global OTC Drug Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN OTC DRUG BUSINESS
8.1 Bayer HealthCare
8.1.1 Bayer HealthCare Company Profile
8.1.2 Bayer HealthCare OTC Drug Product Specification
8.1.3 Bayer HealthCare OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Bristol Myers Squibb
8.2.1 Bristol Myers Squibb Company Profile
8.2.2 Bristol Myers Squibb OTC Drug Product Specification
8.2.3 Bristol Myers Squibb OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Pfizer
8.3.1 Pfizer Company Profile
8.3.2 Pfizer OTC Drug Product Specification
8.3.3 Pfizer OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 GlaxoSmithKline (GSK)
8.4.1 GlaxoSmithKline (GSK) Company Profile
8.4.2 GlaxoSmithKline (GSK) OTC Drug Product Specification
8.4.3 GlaxoSmithKline (GSK) OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 BioGaia
8.5.1 BioGaia Company Profile
8.5.2 BioGaia OTC Drug Product Specification
8.5.3 BioGaia OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson&Johnson
8.6.1 Johnson&Johnson Company Profile
8.6.2 Johnson&Johnson OTC Drug Product Specification
8.6.3 Johnson&Johnson OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Chr. Hansen
8.7.1 Chr. Hansen Company Profile
8.7.2 Chr. Hansen OTC Drug Product Specification
8.7.3 Chr. Hansen OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 AstraZeneca
8.8.1 AstraZeneca Company Profile
8.8.2 AstraZeneca OTC Drug Product Specification
8.8.3 AstraZeneca OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Sanofi
8.9.1 Sanofi Company Profile
8.9.2 Sanofi OTC Drug Product Specification
8.9.3 Sanofi OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Bukwang Pharmaceutica
8.10.1 Bukwang Pharmaceutica Company Profile
8.10.2 Bukwang Pharmaceutica OTC Drug Product Specification
8.10.3 Bukwang Pharmaceutica OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 DSM
8.11.1 DSM Company Profile
8.11.2 DSM OTC Drug Product Specification
8.11.3 DSM OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Herbalife
8.12.1 Herbalife Company Profile
8.12.2 Herbalife OTC Drug Product Specification
8.12.3 Herbalife OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Cipla
8.13.1 Cipla Company Profile
8.13.2 Cipla OTC Drug Product Specification
8.13.3 Cipla OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Eisai
8.14.1 Eisai Company Profile
8.14.2 Eisai OTC Drug Product Specification
8.14.3 Eisai OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 Friggs
8.15.1 Friggs Company Profile
8.15.2 Friggs OTC Drug Product Specification
8.15.3 Friggs OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 CoLucid
8.16.1 CoLucid Company Profile
8.16.2 CoLucid OTC Drug Product Specification
8.16.3 CoLucid OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Euradite
8.17.1 Euradite Company Profile
8.17.2 Euradite OTC Drug Product Specification
8.17.3 Euradite OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Eli Lilly
8.18.1 Eli Lilly Company Profile
8.18.2 Eli Lilly OTC Drug Product Specification
8.18.3 Eli Lilly OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Daiichi Sankyo
8.19.1 Daiichi Sankyo Company Profile
8.19.2 Daiichi Sankyo OTC Drug Product Specification
8.19.3 Daiichi Sankyo OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of OTC Drug (2021-2026)
9.2 Global Forecasted Revenue of OTC Drug (2021-2026)
9.3 Global Forecasted Price of OTC Drug (2015-2026)
9.4 Global Forecasted Production of OTC Drug by Region (2021-2026)
9.4.1 North America OTC Drug Production, Revenue Forecast (2021-2026)
9.4.2 East Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.3 Europe OTC Drug Production, Revenue Forecast (2021-2026)
9.4.4 South Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia OTC Drug Production, Revenue Forecast (2021-2026)
9.4.6 Middle East OTC Drug Production, Revenue Forecast (2021-2026)
9.4.7 Africa OTC Drug Production, Revenue Forecast (2021-2026)
9.4.8 Oceania OTC Drug Production, Revenue Forecast (2021-2026)
9.4.9 South America OTC Drug Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World OTC Drug Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of OTC Drug by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of OTC Drug by Country
10.2 East Asia Market Forecasted Consumption of OTC Drug by Country
10.3 Europe Market Forecasted Consumption of OTC Drug by Countriy
10.4 South Asia Forecasted Consumption of OTC Drug by Country
10.5 Southeast Asia Forecasted Consumption of OTC Drug by Country
10.6 Middle East Forecasted Consumption of OTC Drug by Country
10.7 Africa Forecasted Consumption of OTC Drug by Country
10.8 Oceania Forecasted Consumption of OTC Drug by Country
10.9 South America Forecasted Consumption of OTC Drug by Country
10.10 Rest of the world Forecasted Consumption of OTC Drug by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 OTC Drug Distributors List
11.3 OTC Drug Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 OTC Drug Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global OTC Drug Market Share by Type: 2020 VS 2026
Table 2. Class A Features
Table 3. Class B Features
Table 11. Global OTC Drug Market Share by Application: 2020 VS 2026
Table 12. Hospital Case Studies
Table 13. Clinic Case Studies
Table 14. Household Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. OTC Drug Report Years Considered
Table 29. Global OTC Drug Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global OTC Drug Market Share by Regions: 2021 VS 2026
Table 31. North America OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America OTC Drug Consumption by Countries (2015-2020)
Table 42. East Asia OTC Drug Consumption by Countries (2015-2020)
Table 43. Europe OTC Drug Consumption by Region (2015-2020)
Table 44. South Asia OTC Drug Consumption by Countries (2015-2020)
Table 45. Southeast Asia OTC Drug Consumption by Countries (2015-2020)
Table 46. Middle East OTC Drug Consumption by Countries (2015-2020)
Table 47. Africa OTC Drug Consumption by Countries (2015-2020)
Table 48. Oceania OTC Drug Consumption by Countries (2015-2020)
Table 49. South America OTC Drug Consumption by Countries (2015-2020)
Table 50. Rest of the World OTC Drug Consumption by Countries (2015-2020)
Table 51. Bayer HealthCare OTC Drug Product Specification
Table 52. Bristol Myers Squibb OTC Drug Product Specification
Table 53. Pfizer OTC Drug Product Specification
Table 54. GlaxoSmithKline (GSK) OTC Drug Product Specification
Table 55. BioGaia OTC Drug Product Specification
Table 56. Johnson&Johnson OTC Drug Product Specification
Table 57. Chr. Hansen OTC Drug Product Specification
Table 58. AstraZeneca OTC Drug Product Specification
Table 59. Sanofi OTC Drug Product Specification
Table 60. Bukwang Pharmaceutica OTC Drug Product Specification
Table 61. DSM OTC Drug Product Specification
Table 62. Herbalife OTC Drug Product Specification
Table 63. Cipla OTC Drug Product Specification
Table 64. Eisai OTC Drug Product Specification
Table 65. Friggs OTC Drug Product Specification
Table 66. CoLucid OTC Drug Product Specification
Table 67. Euradite OTC Drug Product Specification
Table 68. Eli Lilly OTC Drug Product Specification
Table 69. Daiichi Sankyo OTC Drug Product Specification
Table 101. Global OTC Drug Production Forecast by Region (2021-2026)
Table 102. Global OTC Drug Sales Volume Forecast by Type (2021-2026)
Table 103. Global OTC Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global OTC Drug Sales Revenue Forecast by Type (2021-2026)
Table 105. Global OTC Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global OTC Drug Sales Price Forecast by Type (2021-2026)
Table 107. Global OTC Drug Consumption Volume Forecast by Application (2021-2026)
Table 108. Global OTC Drug Consumption Value Forecast by Application (2021-2026)
Table 109. North America OTC Drug Consumption Forecast 2021-2026 by Country
Table 110. East Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 111. Europe OTC Drug Consumption Forecast 2021-2026 by Country
Table 112. South Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 114. Middle East OTC Drug Consumption Forecast 2021-2026 by Country
Table 115. Africa OTC Drug Consumption Forecast 2021-2026 by Country
Table 116. Oceania OTC Drug Consumption Forecast 2021-2026 by Country
Table 117. South America OTC Drug Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world OTC Drug Consumption Forecast 2021-2026 by Country
Table 119. OTC Drug Distributors List
Table 120. OTC Drug Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America OTC Drug Consumption and Growth Rate (2015-2020)
Figure 2. North America OTC Drug Consumption Market Share by Countries in 2020
Figure 3. United States OTC Drug Consumption and Growth Rate (2015-2020)
Figure 4. Canada OTC Drug Consumption and Growth Rate (2015-2020)
Figure 5. Mexico OTC Drug Consumption and Growth Rate (2015-2020)
Figure 6. East Asia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 7. East Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 8. China OTC Drug Consumption and Growth Rate (2015-2020)
Figure 9. Japan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 10. South Korea OTC Drug Consumption and Growth Rate (2015-2020)
Figure 11. Europe OTC Drug Consumption and Growth Rate
Figure 12. Europe OTC Drug Consumption Market Share by Region in 2020
Figure 13. Germany OTC Drug Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom OTC Drug Consumption and Growth Rate (2015-2020)
Figure 15. France OTC Drug Consumption and Growth Rate (2015-2020)
Figure 16. Italy OTC Drug Consumption and Growth Rate (2015-2020)
Figure 17. Russia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 18. Spain OTC Drug Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands OTC Drug Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland OTC Drug Consumption and Growth Rate (2015-2020)
Figure 21. Poland OTC Drug Consumption and Growth Rate (2015-2020)
Figure 22. South Asia OTC Drug Consumption and Growth Rate
Figure 23. South Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 24. India OTC Drug Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh OTC Drug Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia OTC Drug Consumption and Growth Rate
Figure 28. Southeast Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 29. Indonesia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 30. Thailand OTC Drug Consumption and Growth Rate (2015-2020)
Figure 31. Singapore OTC Drug Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 33. Philippines OTC Drug Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam OTC Drug Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar OTC Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East OTC Drug Consumption and Growth Rate
Figure 37. Middle East OTC Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey OTC Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran OTC Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates OTC Drug Consumption and Growth Rate (2015-2020)
Figure 42. Israel OTC Drug Consumption and Growth Rate (2015-2020)
Figure 43. Iraq OTC Drug Consumption and Growth Rate (2015-2020)
Figure 44. Qatar OTC Drug Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait OTC Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oman OTC Drug Consumption and Growth Rate (2015-2020)
Figure 47. Africa OTC Drug Consumption and Growth Rate
Figure 48. Africa OTC Drug Consumption Market Share by Countries in 2020
Figure 49. Nigeria OTC Drug Consumption and Growth Rate (2015-2020)
Figure 50. South Africa OTC Drug Consumption and Growth Rate (2015-2020)
Figure 51. Egypt OTC Drug Consumption and Growth Rate (2015-2020)
Figure 52. Algeria OTC Drug Consumption and Growth Rate (2015-2020)
Figure 53. Morocco OTC Drug Consumption and Growth Rate (2015-2020)
Figure 54. Oceania OTC Drug Consumption and Growth Rate
Figure 55. Oceania OTC Drug Consumption Market Share by Countries in 2020
Figure 56. Australia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand OTC Drug Consumption and Growth Rate (2015-2020)
Figure 58. South America OTC Drug Consumption and Growth Rate
Figure 59. South America OTC Drug Consumption Market Share by Countries in 2020
Figure 60. Brazil OTC Drug Consumption and Growth Rate (2015-2020)
Figure 61. Argentina OTC Drug Consumption and Growth Rate (2015-2020)
Figure 62. Columbia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 63. Chile OTC Drug Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal OTC Drug Consumption and Growth Rate (2015-2020)
Figure 65. Peru OTC Drug Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico OTC Drug Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador OTC Drug Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World OTC Drug Consumption and Growth Rate
Figure 69. Rest of the World OTC Drug Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 71. Global OTC Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global OTC Drug Price and Trend Forecast (2015-2026)
Figure 74. North America OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 75. North America OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 79. Europe OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 87. Africa OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 91. South America OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America OTC Drug Consumption Forecast 2021-2026
Figure 95. East Asia OTC Drug Consumption Forecast 2021-2026
Figure 96. Europe OTC Drug Consumption Forecast 2021-2026
Figure 97. South Asia OTC Drug Consumption Forecast 2021-2026
Figure 98. Southeast Asia OTC Drug Consumption Forecast 2021-2026
Figure 99. Middle East OTC Drug Consumption Forecast 2021-2026
Figure 100. Africa OTC Drug Consumption Forecast 2021-2026
Figure 101. Oceania OTC Drug Consumption Forecast 2021-2026
Figure 102. South America OTC Drug Consumption Forecast 2021-2026
Figure 103. Rest of the world OTC Drug Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global OTC Drug Market Share by Type: 2020 VS 2026
Table 2. Class A Features
Table 3. Class B Features
Table 11. Global OTC Drug Market Share by Application: 2020 VS 2026
Table 12. Hospital Case Studies
Table 13. Clinic Case Studies
Table 14. Household Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. OTC Drug Report Years Considered
Table 29. Global OTC Drug Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global OTC Drug Market Share by Regions: 2021 VS 2026
Table 31. North America OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World OTC Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America OTC Drug Consumption by Countries (2015-2020)
Table 42. East Asia OTC Drug Consumption by Countries (2015-2020)
Table 43. Europe OTC Drug Consumption by Region (2015-2020)
Table 44. South Asia OTC Drug Consumption by Countries (2015-2020)
Table 45. Southeast Asia OTC Drug Consumption by Countries (2015-2020)
Table 46. Middle East OTC Drug Consumption by Countries (2015-2020)
Table 47. Africa OTC Drug Consumption by Countries (2015-2020)
Table 48. Oceania OTC Drug Consumption by Countries (2015-2020)
Table 49. South America OTC Drug Consumption by Countries (2015-2020)
Table 50. Rest of the World OTC Drug Consumption by Countries (2015-2020)
Table 51. Bayer HealthCare OTC Drug Product Specification
Table 52. Bristol Myers Squibb OTC Drug Product Specification
Table 53. Pfizer OTC Drug Product Specification
Table 54. GlaxoSmithKline (GSK) OTC Drug Product Specification
Table 55. BioGaia OTC Drug Product Specification
Table 56. Johnson&Johnson OTC Drug Product Specification
Table 57. Chr. Hansen OTC Drug Product Specification
Table 58. AstraZeneca OTC Drug Product Specification
Table 59. Sanofi OTC Drug Product Specification
Table 60. Bukwang Pharmaceutica OTC Drug Product Specification
Table 61. DSM OTC Drug Product Specification
Table 62. Herbalife OTC Drug Product Specification
Table 63. Cipla OTC Drug Product Specification
Table 64. Eisai OTC Drug Product Specification
Table 65. Friggs OTC Drug Product Specification
Table 66. CoLucid OTC Drug Product Specification
Table 67. Euradite OTC Drug Product Specification
Table 68. Eli Lilly OTC Drug Product Specification
Table 69. Daiichi Sankyo OTC Drug Product Specification
Table 101. Global OTC Drug Production Forecast by Region (2021-2026)
Table 102. Global OTC Drug Sales Volume Forecast by Type (2021-2026)
Table 103. Global OTC Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global OTC Drug Sales Revenue Forecast by Type (2021-2026)
Table 105. Global OTC Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global OTC Drug Sales Price Forecast by Type (2021-2026)
Table 107. Global OTC Drug Consumption Volume Forecast by Application (2021-2026)
Table 108. Global OTC Drug Consumption Value Forecast by Application (2021-2026)
Table 109. North America OTC Drug Consumption Forecast 2021-2026 by Country
Table 110. East Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 111. Europe OTC Drug Consumption Forecast 2021-2026 by Country
Table 112. South Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia OTC Drug Consumption Forecast 2021-2026 by Country
Table 114. Middle East OTC Drug Consumption Forecast 2021-2026 by Country
Table 115. Africa OTC Drug Consumption Forecast 2021-2026 by Country
Table 116. Oceania OTC Drug Consumption Forecast 2021-2026 by Country
Table 117. South America OTC Drug Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world OTC Drug Consumption Forecast 2021-2026 by Country
Table 119. OTC Drug Distributors List
Table 120. OTC Drug Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America OTC Drug Consumption and Growth Rate (2015-2020)
Figure 2. North America OTC Drug Consumption Market Share by Countries in 2020
Figure 3. United States OTC Drug Consumption and Growth Rate (2015-2020)
Figure 4. Canada OTC Drug Consumption and Growth Rate (2015-2020)
Figure 5. Mexico OTC Drug Consumption and Growth Rate (2015-2020)
Figure 6. East Asia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 7. East Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 8. China OTC Drug Consumption and Growth Rate (2015-2020)
Figure 9. Japan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 10. South Korea OTC Drug Consumption and Growth Rate (2015-2020)
Figure 11. Europe OTC Drug Consumption and Growth Rate
Figure 12. Europe OTC Drug Consumption Market Share by Region in 2020
Figure 13. Germany OTC Drug Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom OTC Drug Consumption and Growth Rate (2015-2020)
Figure 15. France OTC Drug Consumption and Growth Rate (2015-2020)
Figure 16. Italy OTC Drug Consumption and Growth Rate (2015-2020)
Figure 17. Russia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 18. Spain OTC Drug Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands OTC Drug Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland OTC Drug Consumption and Growth Rate (2015-2020)
Figure 21. Poland OTC Drug Consumption and Growth Rate (2015-2020)
Figure 22. South Asia OTC Drug Consumption and Growth Rate
Figure 23. South Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 24. India OTC Drug Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh OTC Drug Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia OTC Drug Consumption and Growth Rate
Figure 28. Southeast Asia OTC Drug Consumption Market Share by Countries in 2020
Figure 29. Indonesia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 30. Thailand OTC Drug Consumption and Growth Rate (2015-2020)
Figure 31. Singapore OTC Drug Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 33. Philippines OTC Drug Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam OTC Drug Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar OTC Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East OTC Drug Consumption and Growth Rate
Figure 37. Middle East OTC Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey OTC Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran OTC Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates OTC Drug Consumption and Growth Rate (2015-2020)
Figure 42. Israel OTC Drug Consumption and Growth Rate (2015-2020)
Figure 43. Iraq OTC Drug Consumption and Growth Rate (2015-2020)
Figure 44. Qatar OTC Drug Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait OTC Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oman OTC Drug Consumption and Growth Rate (2015-2020)
Figure 47. Africa OTC Drug Consumption and Growth Rate
Figure 48. Africa OTC Drug Consumption Market Share by Countries in 2020
Figure 49. Nigeria OTC Drug Consumption and Growth Rate (2015-2020)
Figure 50. South Africa OTC Drug Consumption and Growth Rate (2015-2020)
Figure 51. Egypt OTC Drug Consumption and Growth Rate (2015-2020)
Figure 52. Algeria OTC Drug Consumption and Growth Rate (2015-2020)
Figure 53. Morocco OTC Drug Consumption and Growth Rate (2015-2020)
Figure 54. Oceania OTC Drug Consumption and Growth Rate
Figure 55. Oceania OTC Drug Consumption Market Share by Countries in 2020
Figure 56. Australia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand OTC Drug Consumption and Growth Rate (2015-2020)
Figure 58. South America OTC Drug Consumption and Growth Rate
Figure 59. South America OTC Drug Consumption Market Share by Countries in 2020
Figure 60. Brazil OTC Drug Consumption and Growth Rate (2015-2020)
Figure 61. Argentina OTC Drug Consumption and Growth Rate (2015-2020)
Figure 62. Columbia OTC Drug Consumption and Growth Rate (2015-2020)
Figure 63. Chile OTC Drug Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal OTC Drug Consumption and Growth Rate (2015-2020)
Figure 65. Peru OTC Drug Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico OTC Drug Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador OTC Drug Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World OTC Drug Consumption and Growth Rate
Figure 69. Rest of the World OTC Drug Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan OTC Drug Consumption and Growth Rate (2015-2020)
Figure 71. Global OTC Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global OTC Drug Price and Trend Forecast (2015-2026)
Figure 74. North America OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 75. North America OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 79. Europe OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 87. Africa OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 91. South America OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World OTC Drug Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World OTC Drug Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America OTC Drug Consumption Forecast 2021-2026
Figure 95. East Asia OTC Drug Consumption Forecast 2021-2026
Figure 96. Europe OTC Drug Consumption Forecast 2021-2026
Figure 97. South Asia OTC Drug Consumption Forecast 2021-2026
Figure 98. Southeast Asia OTC Drug Consumption Forecast 2021-2026
Figure 99. Middle East OTC Drug Consumption Forecast 2021-2026
Figure 100. Africa OTC Drug Consumption Forecast 2021-2026
Figure 101. Oceania OTC Drug Consumption Forecast 2021-2026
Figure 102. South America OTC Drug Consumption Forecast 2021-2026
Figure 103. Rest of the world OTC Drug Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
